Literature DB >> 10419703

Telomerase activity in phyllodes tumours.

K Mokbel1, M Ghilchik, C N Parris, R F Newbold.   

Abstract

AIMS: To investigate telomerase, a ribonucleoprotein that synthesizes telomeres. Recent evidence suggests that telomerase reactivation is associated with the acquisition of immortalization and malignancy.
METHODS: Using a sensitive PCR-based assay (the TRAP assay), we examined telomerase activity in two recurrent phyllodes tumours in two patients.
RESULTS: Both tumours expressed telomerase activity. Histological examination of the lesions, according to the criteria proposed by Azzopardi and Salvadori, revealed a malignant phyllodes tumour in one patient and a benign phyllodes tumour in the other patient.
CONCLUSIONS: Our findings suggest that telomerase activity may have a potential role as a prognostic marker in predicting the clinical behaviour of these rare tumours. Copyright 1999 W.B. Saunders Company Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419703     DOI: 10.1053/ejso.1999.0656

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

Review 1.  Phyllodes tumours.

Authors:  S J Parker; S A Harries
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

2.  TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.

Authors:  Masayuki Yoshida; Reiko Ogawa; Hiroshi Yoshida; Akiko Maeshima; Yae Kanai; Takayuki Kinoshita; Nobuyoshi Hiraoka; Shigeki Sekine
Journal:  Br J Cancer       Date:  2015-09-10       Impact factor: 7.640

3.  Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.

Authors:  Julia Y S Tsang; Yau-Kam Hui; Michelle A Lee; Maribel Lacambra; Yun-Bi Ni; Sai-Yin Cheung; Cherry Wu; Ava Kwong; Gary M K Tse
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.